Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:2348-2358, doi:10.1016/j.jacc.2004.01.047
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lancel, S.
Right arrow Articles by Neviere, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lancel, S.
Right arrow Articles by Neviere, R.

Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats

Steve Lancel, PhD*{dagger}, Stéphanie Tissier, MD*{dagger}, Serge Mordon, PhD*, Xavier Marechal, PhD*{dagger}, Florence Depontieu, PhD{ddagger}, Arnaud Scherpereel, MD, PhD{ddagger}, Claude Chopin, MD* and Remi Neviere, MD, PhD*{dagger},*

* EA 2689, Université de Lille 2, Faculté de Médecine, Lille, France
{dagger} Département de Physiologie, Faculté de Médecine, Lille, France
{ddagger} INSERM U416, Institut Pasteur de Lille, Lille, France



View larger version (14K):

[in a new window]
 
Figure 1 Left ventricular developed pressure (LVDP), maximum rate of left ventricular pressure rise (dP/dtmax), and coronary perfusion pressure (CPP) of isolated and perfused heart from rats treated with saline (control), endotoxin (10 mg/kg), endotoxin and N-nitro-L-arginine methyl ester (LNAME) (50 mg/kg), endotoxin and mercaptoethylguanidine (MEG) sodium succinate (10 mg/kg), and endotoxin and 5,10,15,20-tetrakis(4-sulfonatophenyl)-porphyrinato iron (III) (FeTPPS) (30 mg/kg). See Methods section for treatment group design. Results are expressed as mean ± SEM (n = 8 in each group). *p < 0.01 compared with control; #p < 0.01 compared with endotoxin-treated rats.

 


View larger version (38K):

[in a new window]
 
Figure 2 (A) Plasma rhodamine fluorescence intensity (n = 8 in each group) and (B) representative heart section (n = 3 in each group) stained for nitrotyrosine by immunohistochemistry of rats treated with saline, endotoxin (10 mg/kg), endotoxin and L-NAME (50 mg/kg), endotoxin and MEG sodium succinate (10 mg/kg), and endotoxin and FeTPPS (30 mg/kg). See Methods section for treatment group design. Results are expressed as mean ± SEM. *p < 0.01 compared with control; #p < 0.01 compared with endotoxin-treated rats. Abbreviations as in Figure 1.

 


View larger version (25K):

[in a new window]
 
Figure 3 Effects of L-NAME (50 mg/kg), MEG sodium succinate (10 mg/kg), and FeTPPS (30 mg/kg) on endotoxin-induced heart I-kappa-B degradation and plasma tumor necrosis factor (TNF)-alpha levels. See Methods section for treatment group design. (A) Degradation of I-kappa-B (n = 5 in each group). Semiquantitative analysis was performed on the basis of relative I-kappa-B/G3PDH density. (B) Plasma TNF-alpha levels (n = 6 in each group). Results are expressed as mean ± SEM. *p < 0.01 compared with control; #p < 0.01 compared with endotoxin-treated rats. Abbreviations as in Figure 1.

 


View larger version (15K):

[in a new window]
 
Figure 4 (A) Heart myeloperoxidase activity (n = 6 in each group) and (B) plasma endocan levels (n = 6 in each group) in rats treated with saline, endotoxin (10 mg/kg), endotoxin and LNAME (50 mg/kg), endotoxin and MEG sodium succinate (10 mg/kg), and endotoxin and FeTPPS (30 mg/kg). See Methods section for treatment group design. Results are expressed as mean ± SEM. *p < 0.01 compared with control; #p < 0.01 compared with endotoxin-treated rats. Abbreviations as in Figure 1.

 


View larger version (13K):

[in a new window]
 
Figure 5 Leukocyte behavior in the mesentery venules of rats treated with saline, endotoxin (10 mg/kg), endotoxin and LNAME (50 mg/kg), endotoxin and MEG sodium succinate (10 mg/kg), and endotoxin and FeTPPS (30 mg/kg). See Methods section for treatment group design. Results are expressed as mean ± SEM (n = 6 in each group). *p < 0.01 compared with control; #p < 0.01 compared with endotoxin-treated rats. Abbreviations as in Figure 1.

 


View larger version (28K):

[in a new window]
 
Figure 6 Effects of L-NAME (50 mg/kg), MEG sodium succinate (10 mg/kg), and FeTPPS (30 mg/kg) on endotoxin-induced heart inducible nitric oxide synthase (iNOS) protein expression and plasma nitrite/nitrate levels. See Methods section for treatment group design. (A) Heart iNOS protein expression (n = 6 in each group). Semiquantitative analysis was performed on the basis of relative I-kappa-B/G3PDH density. (B) Plasma nitrite/nitrate levels (n = 6 in each group). Results are expressed as mean ± SEM. *p < 0.01 compared with control; #p < 0.01 compared with endotoxin-treated rats. Abbreviations as in Figure 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement